Two scientists and an editor spent six months investigating so-called paper mills, which churn out bogus scientific papers ...

Patanjali’s Renogrit effectively mitigates kidney damage caused by the cancer drug cisplatin, according to a study published ...

Researchers found that Black and Native American patients were 23% less likely to have high levels of CA-125 when diagnosed with ovarian cancer compared to white patients. That means the test may miss ...

New research reveals a gap in menopause support for breast cancer survivors and a lack of involvement in decision-making ...

Telix Pharmaceuticals reported that the U.S. Food and Drug Administration approved its agent indicated for prostate cancer ...

A new research paper was published by Aging (Aging-US) on March 7, 2025, titled "Accelerated aging associated with cancer characteristics and treatments among breast cancer survivors." ...

As a breast cancer survivor, I feel it is incumbent upon me to give an accurate picture of cancer to others, particularly ...

Renogrit protects against cisplatin-induced renal tubular cell injury without diminishing its anti-cancer properties. The research has been acknowledged among the top 100 papers in the prestigious ...

A previously unknown protein in a family of bacteria found in soil and the human gut microbiome has been discovered—which ...

Bayer, the corporation behind Roundup herbicide, has paid out nearly $11 billion in lawsuits. Trump's EPA might move to block ...

Journalist Robert Fisk who is spearheading our Cancer Care campaign offers a candid look at battling the disease.

A cancer drug developed ten years ago at UCSF can also put the brakes on one of prostate cancer's deadliest molecular tricks.